Home    Back

Engineered protein inhibitor of human neutrophil elastase    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis3

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 1,592 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2004-002341-12-BE
(EUCTR)		05/08/200525/08/2005Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762		Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase		Debiopharm SANULLNot RecruitingFemale: yes
Male: yes		90United Kingdom;Germany;Belgium;Italy
2EUCTR2004-002341-12-GB
(EUCTR)		15/04/200510/02/2005Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762		Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase		Debiopharm SANULLNot RecruitingFemale: yes
Male: yes		90Phase 2Belgium;Germany;Italy;United Kingdom
3EUCTR2004-002341-12-DE
(EUCTR)		14/02/200524/09/2004Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762		Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase		Debiopharm SANULLNot RecruitingFemale: yes
Male: yes		90United Kingdom;Germany;Belgium;Italy